1912herb Co Herbal Sugar Guard

Dosage for Taraxacum Palustre Root is highly individualized and does not follow a standard 'one-size-fits-all' protocol. Because it is a non-standardized extract, dosing is typically expressed in Protein Nitrogen Units (PNU/mL) or weight-to-volume (w/v) dilutions.

Immunotherapy Build-up Phase

• Initial Dose: Typically starts at a very high dilution, such as 1:100,000 w/v or 0.1 PNU/mL.
• Escalation: Doses are increased weekly or bi-weekly by 0.05 mL to 0.1 mL increments, depending on the patient's local reaction and tolerance.
• Target Range: The goal is to reach a maintenance dose, which may range from 0.5 mL of a 1:100 w/v solution to 10,000 PNU/mL, as determined by the allergist.

Maintenance Phase

• Once the maintenance dose is reached, the interval between injections is increased to every 2 to 4 weeks. The dose remains constant unless the patient experiences an adverse reaction or has a long gap between treatments.

Taraxacum Palustre Root allergenic extracts are generally considered safe for use in children, provided the child is old enough to cooperate with the injection procedure and the mandatory 30-minute observation period.

• Dosing Logic: Pediatric dosing follows the same escalation logic as adult dosing, based on immunological sensitivity rather than body weight.
• Age Restrictions: Use in children under the age of 5 requires careful consideration by a specialist, as very young children may have difficulty communicating the early symptoms of a systemic reaction.

Renal Impairment

No specific dosage adjustments are required for patients with renal impairment, as the proteins are not cleared via the kidneys in a manner that would lead to accumulation or toxicity. However, the patient's overall health must be stable.

Hepatic Impairment

No dosage adjustments are necessary for hepatic impairment. The metabolic pathway of proteolytic degradation remains largely unaffected by liver function.

Elderly Patients

Elderly patients require a thorough cardiovascular assessment before beginning therapy. If an elderly patient is taking beta-blockers or ACE inhibitors for age-related conditions, the use of Taraxacum Palustre Root may be contraindicated or require extreme caution due to the risk of refractory anaphylaxis.

Taraxacum Palustre Root extract must NEVER be self-administered. It is strictly for subcutaneous injection performed by a trained medical professional.

• Administration Site: Usually the posterior aspect of the upper arm. The site should be rotated between the left and right arms with each visit.
• Observation: You MUST remain in the medical office for at least 30 minutes after each injection. Most fatal or near-fatal reactions occur within this window.
• Storage: Vials must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light to prevent protein denaturation.

If a dose is missed during the build-up phase, the next dose may need to be reduced to ensure safety.

• Short Delay (1-2 weeks): The previous dose may be repeated.
• Long Delay (3-4 weeks): The dose may be reduced by several increments.
• Extended Absence: Therapy may need to be restarted from the initial dilution. Consult your allergist immediately if you miss an appointment.

An 'overdose' in the context of allergenic extracts refers to the administration of a dose that exceeds the patient's current threshold of tolerance.

• Signs: Rapid onset of hives, swelling of the throat, wheezing, drop in blood pressure, or abdominal cramping.
• Emergency Measures: Immediate administration of epinephrine (1:1000) intramuscularly, followed by antihistamines, corticosteroids, and emergency transport to a hospital if systemic symptoms persist.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

Most patients undergoing treatment with Taraxacum Palustre Root will experience local reactions at the site of injection. These are generally considered a normal part of the body's immune response to the extract.

• Injection Site Erythema: Redness at the site of the shot, which may appear within minutes or hours. It typically feels warm to the touch.
• Local Pruritus: Itching at the injection site. This can be managed with topical hydrocortisone or oral antihistamines as directed by your doctor.
• Local Edema: Swelling or a 'lump' at the site. If the swelling is smaller than the size of a half-dollar (approx. 3 cm), it is usually monitored. If it exceeds this size, the next dose may be adjusted.

• Late-Phase Local Reactions: Swelling and soreness that develops 6 to 24 hours after the injection. This is often more uncomfortable than the immediate reaction and may require cold compresses.
• Fatigue: Some patients report feeling unusually tired for the remainder of the day after receiving their immunotherapy injection.
• Mild Rhinitis: Sneezing or a runny nose shortly after the injection, which usually resolves quickly.

• Generalized Urticaria: Hives appearing on parts of the body far from the injection site.
• Angioedema: Swelling of the deeper layers of the skin, often around the eyes or lips.
• Vasovagal Reactions: Fainting or lightheadedness due to anxiety or the physical sensation of the needle, rather than an allergic reaction.

> Warning: Stop taking Taraxacum Palustre Root and call your doctor immediately if you experience any of these symptoms of anaphylaxis.

• Respiratory Distress: Wheezing, chest tightness, or difficulty breathing. This indicates bronchospasm and requires immediate epinephrine.
• Laryngeal Edema: A 'tightness' in the throat or difficulty swallowing, which can signal airway obstruction.
• Hypotension: A sudden drop in blood pressure, which may present as extreme dizziness, confusion, or loss of consciousness.
• Cyanosis: A bluish tint to the lips or fingernails, indicating a lack of oxygen.
• Persistent Gastrointestinal Distress: Nausea, vomiting, or intense abdominal cramping that occurs immediately following an injection.

Immunotherapy with Taraxacum Palustre Root is generally intended for a duration of 3 to 5 years.

• Immunological Memory: The primary long-term 'effect' is the desired desensitization. However, if the therapy is stopped prematurely, symptoms may return.
• Autoimmune Concerns: While rare, there has been theoretical discussion regarding the stimulation of the immune system and the potential for triggering underlying autoimmune conditions. Current clinical data from the AAAAI (American Academy of Allergy, Asthma & Immunology) suggests that this risk is extremely low in the general population.

Taraxacum Palustre Root, like all allergenic extracts, carries a significant risk of severe systemic reactions.

• Anaphylaxis Risk: This product can cause life-threatening anaphylactic shock. It should only be administered in a clinical setting equipped with emergency resuscitative equipment, including oxygen, IV fluids, and epinephrine.
• Asthma Warning: Patients with unstable or severe asthma are at a significantly higher risk for fatal reactions and should not receive immunotherapy until their asthma is well-controlled.

Report any unusual symptoms to your healthcare provider.

Taraxacum Palustre Root extract is a potent biological agent. Its use requires a commitment to safety protocols, including the mandatory observation period. Patients must be in a stable state of health on the day of their injection; for example, if you have a fever or an active asthma flare-up, your injection should be postponed.

No FDA black box warnings for Taraxacum Palustre Root specifically, but it falls under the general class warning for all allergenic extracts regarding the risk of severe systemic allergic reactions (anaphylaxis). The labeling for these products emphasizes that they must be administered by physicians who are exceptionally experienced in the treatment of anaphylaxis and that patients must be observed for a minimum of 30 minutes post-injection.

• Allergic Reactions / Anaphylaxis Risk: The primary risk is a systemic IgE-mediated reaction. Patients with a history of high sensitivity (e.g., those who react strongly to skin tests) must be escalated more slowly.
• Beta-Blocker Use: Patients taking beta-blockers (including eye drops) may be resistant to the effects of epinephrine, the primary treatment for anaphylaxis. This makes any allergic reaction much more dangerous.
• Asthma Status: Your healthcare provider will check your lung function (often via peak flow) before each injection. If your asthma is not controlled, the risk of a fatal respiratory reaction increases significantly.
• Concurrent Illness: Viral infections can lower the threshold for a systemic reaction. Always inform your nurse if you are feeling unwell.

• Peak Flow Monitoring: For patients with asthma, regular monitoring of peak expiratory flow is essential.
• Skin Test Reactivity: Periodic re-evaluation of skin test sensitivity may be performed to assess the progress of the immunotherapy.
• Observation Log: Clinical staff will maintain a log of your local reactions (measured in millimeters) to determine the safety of the next dose increase.

While Taraxacum Palustre Root does not directly cause sedation, the occurrence of a systemic reaction or the administration of emergency antihistamines can significantly impair your ability to drive. It is recommended that you do not engage in strenuous exercise for at least 2 hours after an injection, as increased blood flow can accelerate the absorption of the allergen.

Alcohol consumption should be avoided on the day of your injection. Alcohol can cause vasodilation, which may potentially increase the speed at which the allergen enters the bloodstream, thereby increasing the risk of a systemic reaction.

If you decide to stop Taraxacum Palustre Root therapy, you should discuss this with your allergist. Unlike some medications, there is no physical 'withdrawal' syndrome. However, stopping before the 3-to-5-year mark significantly increases the likelihood that your allergy symptoms will return to their baseline severity.

> Important: Discuss all your medical conditions with your healthcare provider before starting Taraxacum Palustre Root.

• Beta-Adrenergic Blockers: Drugs like propranolol, metoprolol, or even timolol eye drops are contraindicated or used with extreme caution. The clinical consequence is that if you have an anaphylactic reaction to the Taraxacum Palustre Root, the standard life-saving dose of epinephrine may not work, leading to refractory shock.
• Uncontrolled Asthma Medications: If a patient requires high-dose rescue inhalers daily, they should not be on immunotherapy until stabilized.

• ACE Inhibitors: Medications such as lisinopril or enalapril can increase the risk of severe angioedema (swelling) and may worsen the severity of an allergic reaction by interfering with the breakdown of bradykinin.
• MAOIs and TCAs: Monoamine oxidase inhibitors and tricyclic antidepressants can potentiate the effects of epinephrine if it needs to be administered, potentially leading to a hypertensive crisis.

• Other Immunotherapy: If you are receiving injections for multiple allergens (e.g., grasses, molds, dust mites), the doses must be carefully coordinated to avoid 'stacking' the systemic immune load, which increases the risk of a reaction.
• Antihistamines: While often used to manage local symptoms, taking a strong antihistamine right before a skin test will cause a false-negative result. For immunotherapy, they may mask the early 'warning signs' of a systemic reaction.

• Cross-Reactive Foods: Individuals sensitive to Taraxacum Palustre Root may experience Oral Allergy Syndrome (OAS) when eating related foods such as chamomile tea, sunflower seeds, or honey. These interactions are pharmacodynamic, where the immune system confuses the food proteins with the dandelion proteins.
• Alcohol: As mentioned, alcohol can increase the rate of allergen absorption and should be avoided for several hours post-injection.

• Echinacea: Since Echinacea is also a member of the Asteraceae family, taking it concurrently with Taraxacum Palustre Root injections may increase the risk of an allergic flare-up.
• Chamomile: Often used in herbal teas, chamomile can cause cross-reactive allergic symptoms in dandelion-sensitive patients.

• Skin Testing: Taraxacum Palustre Root will obviously interfere with any future skin tests for dandelion sensitivity.
• In Vitro IgE Tests (ImmunoCAP): The presence of the extract in the system does not typically interfere with blood tests for IgE, but the immunotherapy itself is designed to eventually lower these levels over years.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

• Severe, Uncontrolled Asthma: Patients whose FEV1 (Forced Expiratory Volume) is consistently below 70% of predicted value should not receive Taraxacum Palustre Root. The risk of a fatal bronchospasm during a systemic reaction is too high.
• Recent Myocardial Infarction (Heart Attack): The stress of a potential systemic reaction and the subsequent need for epinephrine can be fatal in a patient with an unstable cardiovascular system.
• History of Severe Anaphylaxis to this Specific Extract: If a patient has previously had a near-fatal reaction to Taraxacum Palustre Root, the risks of continuing therapy usually outweigh the benefits.

• Autoimmune Diseases: Patients with active systemic lupus erythematosus (SLE) or rheumatoid arthritis may experience a flare-up of their condition due to the general stimulation of the immune system.
• Malignancy: Patients undergoing active chemotherapy or with unstable cancers are generally not started on immunotherapy.
• Beta-Blocker Therapy: While not always an absolute contraindication, it requires a very careful risk-benefit analysis by the physician.

Patients who are known to be severely allergic to other members of the Asteraceae family (such as Ragweed, Chrysanthemums, Marigolds, or Daisies) are at a higher risk of reacting to Taraxacum Palustre Root. This is due to the presence of conserved proteins across these species. Your doctor will perform a 'graded' skin test if cross-sensitivity is suspected.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Taraxacum Palustre Root.

Taraxacum Palustre Root is classified as Pregnancy Category C.

• Risk Summary: There are no adequate and well-controlled studies in pregnant women. However, the primary risk is not teratogenicity (birth defects) from the extract itself, but rather the danger posed to the fetus by maternal anaphylaxis and the resulting hypoxia (lack of oxygen).
• Clinical Practice: Doctors generally do not start new immunotherapy during pregnancy. However, if a woman is already on a stable maintenance dose and is tolerating it well, the therapy may be continued at that same dose (or a slightly reduced dose) throughout the pregnancy.

It is generally considered safe to continue Taraxacum Palustre Root immunotherapy while breastfeeding. The large allergenic proteins are digested in the mother's gut and are not expected to pass into breast milk in any form that would sensitize or harm the nursing infant. There is no evidence that it affects milk production.

As discussed in the dosage section, Taraxacum Palustre Root is used in children, typically starting at age 5.

• Growth Effects: There is no evidence that allergenic extracts affect growth or development.
• Special Considerations: The main challenge is the child's ability to tolerate the injections and the 30-minute wait. Injections should never be forced on a highly distressed child, as this can lead to vasovagal episodes that mimic allergic reactions.

In patients over 65, the decision to use Taraxacum Palustre Root must involve a thorough cardiac screening.

• Cardiovascular Risk: Older adults are more likely to have underlying coronary artery disease, making them poor candidates for the epinephrine required to treat a reaction.
• Polypharmacy: The higher likelihood of being on ACE inhibitors or beta-blockers increases the complexity of treatment.

No specific studies have been conducted in patients with renal failure. However, since the proteins are not renally excreted, no dose adjustment is theoretically necessary. The patient must be hemodynamically stable.

Similarly, hepatic impairment does not affect the proteolytic degradation of the extract components. No adjustments are required for patients with cirrhosis or other liver diseases, provided they are otherwise stable candidates for immunotherapy.

> Important: Special populations require individualized medical assessment.

Taraxacum Palustre Root extract induces immunological tolerance through several distinct pathways:

1. 1T-Cell Modulation: It promotes the differentiation of T-regulatory (Treg) cells. These cells produce IL-10, which suppresses the allergic inflammation caused by Th2 cells.
2. 2Antibody Class Switching: Over time, the immune system shifts from producing IgE (the 'allergy' antibody) to producing IgG4 (the 'blocking' antibody). IgG4 intercepts the dandelion allergens before they can reach the IgE on mast cells.
3. 3Mast Cell Desensitization: Continuous exposure to sub-threshold levels of the allergen reduces the sensitivity of mast cells and basophils, making them less likely to release histamine.

• Onset of Effect: Diagnostic skin tests work within 15-20 minutes. For immunotherapy, clinical improvement typically takes 6 to 12 months of consistent treatment.
• Duration of Effect: The goal is permanent or long-term desensitization. If a full 3-to-5-year course is completed, the effects can last for many years or even a lifetime.
• Tolerance: Unlike drugs where tolerance means the drug stops working, 'tolerance' here is the therapeutic goal—the body learns to tolerate the allergen.

| Parameter | Value |

|---|---|

| Bioavailability | N/A (Subcutaneous) |

| Protein Binding | N/A (Proteins themselves) |

| Half-life | Variable (Hours to Days for proteins) |

| Tmax | 1-2 hours (Local absorption) |

| Metabolism | Proteolytic degradation |

| Excretion | Minimal renal excretion |

• Molecular Formula: Complex mixture (not a single formula) |
• Molecular Weight: Ranges from 10 kDa to >100 kDa (Proteins) |
• Solubility: Soluble in aqueous saline and glycerin solutions |
• Structure: Contains sesquiterpene lactones, triterpenes, and various phenolic compounds common to the Taraxacum genus.

Taraxacum Palustre Root belongs to the class of Non-Standardized Plant Allergenic Extracts. It is grouped with other botanical extracts like Ragweed, Oak, and Timothy Grass extracts used in allergy clinics.